PSI CRO Adopts goBalto Platform

Published on: September 13, 2016

PSI CRO has chosen goBalto’s end-to-end study startup platform for conducting clinical trials from site identification, feasibility and selection through to site activation.

PSI CRO has chosen goBalto’s end-to-end study startup platform for conducting clinical trials from site identification, feasibility and selection through to site activation. PSI CRO will apply the platform for use in a multi-country Phase II Infectious Disease Study.

Read the full release here